BidaskClub upgraded shares of Merit Medical Systems (NASDAQ:MMSI) from a sell rating to a hold rating in a research report sent to investors on Saturday morning.
Other equities analysts have also recently issued reports about the company. Zacks Investment Research cut Merit Medical Systems from a buy rating to a hold rating in a research note on Thursday, January 25th. ValuEngine cut Merit Medical Systems from a buy rating to a hold rating in a research note on Friday, December 1st. SunTrust Banks set a $47.00 target price on Merit Medical Systems and gave the company a buy rating in a research note on Thursday, November 16th. Canaccord Genuity increased their target price on Merit Medical Systems from $45.00 to $47.50 and gave the company a buy rating in a research note on Thursday, October 26th. Finally, Wells Fargo & Co reiterated an outperform rating and set a $51.00 target price (up from $46.00) on shares of Merit Medical Systems in a research note on Thursday, November 30th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company has an average rating of Buy and an average target price of $43.77.
Merit Medical Systems (NASDAQ:MMSI) opened at $45.70 on Friday. The company has a market capitalization of $2,294.09, a P/E ratio of 35.98, a PEG ratio of 2.68 and a beta of 1.29. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. Merit Medical Systems has a one year low of $27.65 and a one year high of $48.10.
In related news, Director Franklin J. Miller sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, December 29th. The stock was sold at an average price of $43.93, for a total transaction of $439,300.00. Following the sale, the director now directly owns 21,244 shares of the company’s stock, valued at approximately $933,248.92. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Kent W. Stanger sold 9,082 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $44.90, for a total value of $407,781.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,000 shares of company stock worth $1,416,379. Corporate insiders own 5.00% of the company’s stock.
Several hedge funds have recently bought and sold shares of the stock. We Are One Seven LLC acquired a new stake in shares of Merit Medical Systems during the 4th quarter valued at approximately $170,000. BRYN MAWR TRUST Co increased its position in Merit Medical Systems by 2.2% in the fourth quarter. BRYN MAWR TRUST Co now owns 158,732 shares of the medical instruments supplier’s stock worth $6,858,000 after buying an additional 3,408 shares during the period. Martin & Co. Inc. TN increased its position in Merit Medical Systems by 31.9% in the fourth quarter. Martin & Co. Inc. TN now owns 59,760 shares of the medical instruments supplier’s stock worth $2,582,000 after buying an additional 14,440 shares during the period. MetLife Investment Advisors LLC acquired a new stake in Merit Medical Systems in the fourth quarter worth $1,007,000. Finally, Municipal Employees Retirement System of Michigan increased its position in Merit Medical Systems by 22.9% in the fourth quarter. Municipal Employees Retirement System of Michigan now owns 23,200 shares of the medical instruments supplier’s stock worth $1,003,000 after buying an additional 4,330 shares during the period. 87.44% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Merit Medical Systems (MMSI) Upgraded by BidaskClub to “Hold”” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/18/merit-medical-systems-mmsi-upgraded-by-bidaskclub-to-hold-2.html.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.